BiLab revolutionizes cardiopulmonary monitoring with its state-of-the-art technology of electrical impedance tomography (EIT). Noninvasive continuous monitoring of tidal volume and stroke volume is now possible through cross-sectional EIT imaging of the chest.

BiLab’s innovative EIT technology can enhance patient safety and recovery at reduced costs.  Providing pathbreaking solutions to cardiopulmonary monitoring, BiLab supports clinical research to improve patient outcomes using this revolutionary image-based monitoring technology.



  • GMP certification from the MFDS in Korea
  • AirTom-R approval from the MFDS in Korea
  • Series A funding from a strategic investor


  • Product design and sample production
  • Animal studies and volunteer studies
  • GMP and medical device approval processes


  • Seed funding from Innopolis Partners
  • Patents transfer from Kyung Hee University
  • Prototype EIT system development
  • Animal studies and clinical studies


  • Founded in July 2016
  • Technology transfer from Impedance Imaging Research Center (IIRC)

Founder & acting CTO

Eung Je Woo, Ph.D.

30 years of EIT R&D with
over $15M grants

Chairman of the board

Yongmin Kim, Ph.D.

37 years of medical devices R&D,
former President of POSTECH


Jun Chang

17 years of experience in medical
device product development

Product development & manufacturing

Hun Wi, Ph.D.

12 years of EIT hardware

Gwang Woo Kong

17 years of experience in medical
device manufacturing

Marketing & sales

Jin Soo Park

30 years of experience in
trading business